NOTIFICATION OF TRADE AMONG PRIMARY INSIDERS

On 14 April 2010 mandatory notifications of trade among primary insiders

of DiaGenic ASA took place. The primary insiders have sold a total of

240,000 shares. In addition the primary insiders have entered into Total

Return equity Swap (TRS) agreements with exposure for 240,000 shares in

DiaGenic. Net exposure among the insiders is unchanged by these

transactions. The transactions are described in more detail below.

Håkon Sæterøy, Executive Chairman of the Board of DiaGenic ASA, has

through Investor Corporate AS, which is controlled by Sæterøy, sold

200,000 shares at NOK 3.55 per share. Sæterøy subsequently entered into

a Total Return equity Swap agreement (TRS) with exposure of 200,000

underlying shares. Expiry date is 14 July 2010, and the TRS price is NOK

3.59 per share. After these transactions, Sæterøy directly and

indirectly owns a total of 978,668 shares and 229,801 warrants, in

addition to two TRS agreements with exposure for 335,000 shares.

Director Dag Christian Christiansen today sold 40,000 shares at NOK 3.55

per share. Christiansen has subsequently entered into a Total Return

equity Swap agreement (TRS) with exposure of 40,000 underlying shares.

Expiry date is 14 July 2010, and the TRS price is NOK 3.59 per share.

After the transactions Christiansen owns a total of 220,000 shares and

10,000 warrants in DiaGenic, in addition to the TRS agreement with

exposure for 40,000 shares.

This information is subject of the disclosure requirements acc. to §5-12

vphl (Norwegian Securities Trading Act).

Contact:

MD PhD Erik Christensen, Managing Director

Telephone: +47 95939918

AI Terminal